Insmed (INSM) Reiterated at Overweight by Cantor Fitzgerald

June 10, 2026 7:02 AM

Cantor Fitzgerald analyst Olivia Brayer reiterated an Overweight rating and $235.00 price target on Insmed (NASDAQ: INSM).The analyst commented, "One ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found